2,6-Dimethylmorpholine, cis- → 2,6-Dimethyl-4-[2-methyl-2-(4-nitro-imidazol-1-yl)-propyl]-morpholine
Reaction equation
[CH3:1][C:2]([N:6]1[CH:10]=[C:9]([N+:11]([O-:13])=[O:12])[N:8]=[CH:7]1)([CH3:5])[CH:3]=O.[CH3:14][C@H:15]1[O:20][C@@H:19]([CH3:21])[CH2:18][NH:17][CH2:16]1>>[CH3:21][CH:19]1[O:20][CH:15]([CH3:14])[CH2:16][N:17]([CH2:3][C:2]([CH3:1])([N:6]2[CH:10]=[C:9]([N+:11]([O-:13])=[O:12])[N:8]=[CH:7]2)[CH3:5])[CH2:18]1Participants
3
Procedure
2-Methyl-2-(4-nitro-imidazol-1-yl)-propionaldehyde was reacted with cis-2,6-dimethyl morpholine to provide the title compound: C13 NMR (100 MHz, CDCl3) 19.0, 25.7, 60.8, 61.5, 68.5, 72.0, 118.0, 134.5; MS m/z 283.2 (M+1).
Sources & evidence
- ORD record
- ord-a2b0578a18b14d95b3d8d2aaa70a9d08
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07342118B2
Reaction notes
Loading…